SB INVESTMENT ADVISERS (UK) LTD
Holdings History for Vir Biotechnology, Inc. - Common Stock (VIR)
- Symbol
- VIR on Nasdaq
- Investment type
- Equity / Common Stock
- Latest Disclosed Shares Owned
- 13,116,977 shares
- Security Ownership %
- 9.4%
Shares, Excluding Options vs Price
Value, Excluding Options
SB Investment Advisers (UK) Limited ownership in Vir Biotechnology, Inc. Common Stock (VIR)
17 Feb 2026 - SB Investment Advisers (UK) Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,116,977 shares of Vir Biotechnology, Inc. Common Stock (VIR).
This represents 9.4% ownership of the company.
This is the first filing by SB INVESTMENT ADVISERS (UK) LTD disclosing ownership of Vir Biotechnology, Inc. Common Stock (VIR).
| Reporting Name | Ownership % | Change | Value $ | Shares owned | Change | Activity % | Price | Form | Report date | Filing time |
|---|---|---|---|---|---|---|---|---|---|---|
| SB Investment Advisers (UK) Limited | 9.4% | $77,652,504 | 13,116,977 | $5.92 | 13G/A | 31 Dec 2025 | 17 Feb 2026, 17:00 |
| Holdings date | Option | Weight | Change | Value $ | Shares | Change | Activity % | Price | All Holders |
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2025 | 0.79% | -0.22% | $79,095,371 | 13,116,977 | -3,567,064 | -21% | $6.03 | Q4 2025 | |
| 30 Sep 2025 | 0.72% | 0% | $95,265,874 | 16,684,041 | 0 | $5.71 | Q3 2025 | ||
| 30 Jun 2025 | 0.67% | 0% | $84,087,567 | 16,684,041 | 0 | $5.04 | Q2 2025 | ||
| 31 Mar 2025 | 0.99% | 0% | $108,112,586 | 16,684,041 | 0 | $6.48 | Q1 2025 | ||
| 31 Dec 2024 | 1.1% | 0% | $122,460,861 | 16,684,041 | 0 | $7.34 | Q4 2024 | ||
| 30 Sep 2024 | 1% | 0% | $124,963,467 | 16,684,041 | 0 | $7.49 | Q3 2024 | ||
| 30 Jun 2024 | 1.4% | 0% | $148,487,965 | 16,684,041 | 0 | $8.90 | Q2 2024 | ||
| 31 Mar 2024 | 1.7% | 0% | $169,009,335 | 16,684,041 | 0 | $10.13 | Q1 2024 | ||
| 31 Dec 2023 | 1.5% | 0% | $167,841,452 | 16,684,041 | 0 | $10.06 | Q4 2023 | ||
| 30 Sep 2023 | 1.3% | 0% | $156,329,464 | 16,684,041 | 0 | $9.37 | Q3 2023 | ||
| 30 Jun 2023 | 3.1% | -0.31% | $409,259,526 | 16,684,041 | -1,635,897 | -8.9% | $24.53 | Q2 2023 | |
| 31 Mar 2023 | 3.5% | -0.37% | $426,304,957 | 18,319,938 | -1,939,597 | -9.6% | $23.27 | Q1 2023 | |
| 31 Dec 2022 | 4.3% | -0.39% | $512,768,831 | 20,259,535 | -1,826,745 | -8.3% | $25.31 | Q4 2022 | |
| 30 Sep 2022 | 3.3% | -0.02% | $425,823,000 | 22,086,280 | -130,364 | -0.59% | $19.28 | Q3 2022 | |
| 30 Jun 2022 | 4.5% | 0% | $565,858,000 | 22,216,644 | 0 | $25.47 | Q2 2022 | ||
| 31 Mar 2022 | 2.7% | 0% | $571,412,000 | 22,216,644 | 0 | $25.72 | Q1 2022 | ||
| 31 Dec 2021 | 2.7% | -0.05% | $930,211,000 | 22,216,644 | -400,022 | -1.8% | $41.87 | Q4 2021 | |
| 30 Sep 2021 | 3.1% | 0% | $984,277,000 | 22,616,666 | 0 | $43.52 | Q3 2021 | ||
| 30 Jun 2021 | 2.1% | 0% | $1,069,315,000 | 22,616,666 | 0 | $47.28 | Q2 2021 | ||
| 31 Mar 2021 | 2% | 0% | $1,159,556,000 | 22,616,666 | 0 | $51.27 | Q1 2021 | ||
| 31 Dec 2020 | 2.4% | 0% | $605,674,000 | 22,616,666 | 0 | $26.78 | Q4 2020 | ||
| 30 Sep 2020 | 6.7% | 0% | $776,430,000 | 22,616,666 | 0 | $34.33 | Q3 2020 | ||
| 30 Jun 2020 | 10% | 0% | $926,605,000 | 22,616,666 | 0 | $40.97 | Q2 2020 | ||
| 31 Mar 2020 | 8.4% | 0% | $775,073,000 | 22,616,666 | 0 | $34.27 | Q1 2020 | ||
| 31 Dec 2019 | 3.1% | +3.1% | $284,405,000 | 22,616,666 | +22,616,666 | NEW | $12.58 | Q4 2019 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.